Testing for Protein Loss in Digestive System

The provider analyzes the stool after intravenous injection of a patient with a radiopharmaceutical or tracer. The analysis detects and quantifies an abnormal loss of protein from the digestive tract or the inability of the digestive tract to absorb proteins. This occurs from conditions such as bacteria or parasite infection of the intestines, Crohn’s disease, lymphoma, or other diseases. Choose a location to see hospital-reported price summaries. This page does not show national, sample, or aggregate pricing.